Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | SIRTURO® (bedaquiline) | Official Website | About |
Description | SIRTURO® Is the First Medication for Pulmonary MDR-TB With a Novel Mechanism of Action in Over 40 SIRTURO Homepage. See full prescribing information including boxed |
Keywords | SIRTURO,bedaquiline,TB,tuberculosis,MDR,multi-drug resistant,treatment,indication,use,usage,limitations,MOA,mechanism,ATP synthase inhibitor,diarylquinoline,directly observed therapy |
WebSite | sirturo.com |
Host IP | 18.165.122.81 |
Location | United States |
Site | Rank |
US$5,602,556
Last updated: 2023-05-19 19:09:35
sirturo.com has Semrush global rank of 1,889,192. sirturo.com has an estimated worth of US$ 5,602,556, based on its estimated Ads revenue. sirturo.com receives approximately 646,449 unique visitors each day. Its web server is located in United States, with IP address 18.165.122.81. According to SiteAdvisor, sirturo.com is safe to visit. |
Purchase/Sale Value | US$5,602,556 |
Daily Ads Revenue | US$5,172 |
Monthly Ads Revenue | US$155,148 |
Yearly Ads Revenue | US$1,861,773 |
Daily Unique Visitors | 43,097 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
sirturo.com. | A | 1800 | IP: d2rvwveo8xr3cq.cloudfront.net. |
d2rvwveo8xr3cq.cloudfront.net. 59 IN | A | IP: 18.165.122.81 | |
d2rvwveo8xr3cq.cloudfront.net. 59 IN | A | IP: 18.165.122.121 | |
d2rvwveo8xr3cq.cloudfront.net. 59 IN | A | IP: 18.165.122.110 | |
d2rvwveo8xr3cq.cloudfront.net. 59 IN | A | IP: 18.165.122.102 | |
sirturo.com. | AAAA | 1799 | IPV6: d2rvwveo8xr3cq.cloudfront.net. |
sirturo.com. | NS | 1799 | NS Record: d2rvwveo8xr3cq.cloudfront.net. |
d2rvwveo8xr3cq.cloudfront.net. 86400 IN | NS | NS Record: ns-468.awsdns-58.com. | |
d2rvwveo8xr3cq.cloudfront.net. 86400 IN | NS | NS Record: ns-995.awsdns-60.net. | |
d2rvwveo8xr3cq.cloudfront.net. 86400 IN | NS | NS Record: ns-1281.awsdns-32.org. | |
d2rvwveo8xr3cq.cloudfront.net. 86400 IN | NS | NS Record: ns-1681.awsdns-18.co.uk. | |
sirturo.com. | MX | 1799 | MX Record: d2rvwveo8xr3cq.cloudfront.net. |
sirturo.com. | TXT | 1799 | TXT Record: d2rvwveo8xr3cq.cloudfront.net. |
FOR HEALTHCARE PROFESSIONALS IN THE US AND PUERTO RICO ONLY Home Important Safety Information --> Prescribing Information Medication Guide Medical Information Center 1-800-JANSSEN Email Search Multi-drug Resistant TB About SIRTURO ® SIRTURO ® Clinical Trials SIRTURO ® Appropriate Use SIRTURO ® Is the First Medication for Pulmonary MDR-TB With a Novel Mechanism of Action in Over 40 Years --> Mechanism of Action SIRTURO ® is the first anti-TB drug to interfere with bacterial energy metabolism. SIRTURO ® specifically inhibits mycobacterial ATP (adenosine 5’-triphosphate) synthase, by binding to subunit c of the enzyme that is essential for the generation of energy in Mycobacterium tuberculosis. Download a comprehensive resource on SIRTURO ® (bedaquiline) tablets Janssen Therapeutics Medical Information Center Legal Notice --> References Do not sell my personal information --> Janssen Therapeutics, Division of Janssen Products, LP © Janssen Therapeutics, Division of Janssen |
HTTP/1.1 301 Moved Permanently Server: CloudFront Date: Fri, 11 Nov 2022 08:53:26 GMT Content-Type: text/html Content-Length: 167 Connection: keep-alive Location: https://sirturo.com/ X-Cache: Redirect from cloudfront Via: 1.1 4e08e102c2732c67db56ba7b7c275360.cloudfront.net (CloudFront) X-Amz-Cf-Pop: WAW51-P2 X-Amz-Cf-Id: AkIC7V5hY3IUMp1ar6n76l5h7CGgB1DrbZxpUPCMkLcFcP6R5iiDTw== X-XSS-Protection: 1; mode=block X-Frame-Options: SAMEORIGIN Referrer-Policy: same-origin Content-Security-Policy: default-src *; script-src * 'unsafe-eval' 'self' 'unsafe-inline' https:; style-src * 'unsafe-inline'; object-src 'self' *.youtube.com youtube.com; img-src * data:; frame-src *; font-src * data:; connect-src *; media-src * blob:; worker-src 'self' blob:; X-Content-Type-Options: nosniff HTTP/1.1 200 OK Content-Type: text/html Content-Length: 21794 Connection: keep-alive Last-Modified: Fri, 04 Nov 2022 12:24:22 GMT Server: AmazonS3 Date: Fri, 11 Nov 2022 08:53:27 GMT Cache-Control: max-age=3600 ETag: "d93c9939a453929f38697e53273356fa" X-Cache: RefreshHit from cloudfront Via: 1.1 a8d99ef797d085739f567e661bc20536.cloudfront.net (CloudFront) X-Amz-Cf-Pop: WAW51-P2 X-Amz-Cf-Id: iaOYAXFdBOCFR5JzxRuW0xyf8qwVvOu4hlpiAAZS7SyMKW3lS78k0A== X-XSS-Protection: 1; mode=block X-Frame-Options: SAMEORIGIN Referrer-Policy: same-origin Content-Security-Policy: default-src *; script-src * 'unsafe-eval' 'self' 'unsafe-inline' https:; style-src * 'unsafe-inline'; object-src 'self' *.youtube.com youtube.com; img-src * data:; frame-src *; font-src * data:; connect-src *; media-src * blob:; worker-src 'self' blob:; X-Content-Type-Options: nosniff Strict-Transport-Security: max-age=63072000; includeSubDomains; preload |
Domain Name: SIRTURO.COM Registry Domain ID: 1648235490_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.rrpproxy.net Registrar URL: http://www.key-systems.net Updated Date: 2022-02-26T15:01:41Z Creation Date: 2011-03-30T12:34:25Z Registry Expiry Date: 2023-03-30T12:34:25Z Registrar: Key-Systems GmbH Registrar IANA ID: 269 Registrar Abuse Contact Email: abuse@key-systems.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.JNJ.COM Name Server: NS3.JNJ.COM Name Server: NS5.JNJ.COM DNSSEC: unsigned >>> Last update of whois database: 2022-11-11T08:56:45Z <<< |